BioSpace News Archive

Onconova Therapeutics, Inc. today announced that it will participate in the MedInvest Oncology Investor Conference being held in New York, NY on December 14-15, 2022.

BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today issued a letter to shareholders.

The DINAMO phase III clinical trial met its primary endpoint by demonstrating a statistically significant reduction in HbA1c (a marker of average blood sugar) with Jardiance® (empagliflozin) compared with placebo for children and adolescents aged 10-17 years living with type 2 diabetes.

Sionna Therapeutics today announced the clearance of its Investigational New Drug application (IND) from the U.S. Food and Drug Administration (FDA) for SION-638, a novel small molecule designed to target the first nucleotide-binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.

Mission Bio and academic partners are presenting data from the company’s Tapestri® Platform on a range of topics at the 64th Annual American Society of Hematology (ASH) Annual Meeting and Exposition, beginning this weekend in New Orleans, LA.

The Baszucki Brain Research Fund is proud to announce Dr. Iain Campbell as its first Metabolic Psychiatry Research Fellow.

Thermo Fisher Scientific Inc. today announced that its SeCore CDx HLA Sequencing System was granted De Novo Classification by the United States Food and Drug Administration (FDA) for use as a companion diagnostic with KIMMTRAK ®.

Ankyra Therapeutics today announced that Leisha A. Emens, M.D., Ph.D., has been appointed as senior vice president, translational research.

Altoida, Inc. today announced key appointments across clinical affairs, marketing, and operations to support the continued advancement of its digital phenotypes and programs.

Abata Therapeutics today announced that it has appointed Ellen Cahir-McFarland, Ph.D., as its Chief Scientific Officer.